Complete polyp resection with cold snare versus hot snare polypectomy for polyps of 4-9 mm: a randomized controlled trial.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 11 1 2022
medline: 28 9 2022
entrez: 10 1 2022
Statut: ppublish

Résumé

Endoscopic screening with polypectomy reduces the incidence of colorectal cancer (CRC). Incomplete polyp removal may attenuate the effect of screening. This randomized trial compared cold snare polypectomy (CSP) with hot snare polypectomy (HSP) in terms of complete polyp resection. We included patients ≥ 40 years of age at eight hospitals in four countries who had at least one non-pedunculated polyp of 4-9 mm detected at colonoscopy. Patients were randomized 1:1 to CSP or HSP. Biopsies from the resection margins were obtained systematically after polypectomy in both groups. We hypothesized that CSP would be non-inferior to HSP, with a non-inferiority margin of 5 %. Logistic regression models were fitted to identify the factors explaining incomplete resection. 425 patients, with 601 polyps, randomized to either CSP or HSP were included in the analysis. Of 318 polyps removed by CSP and 283 polyps removed by HSP, 34 (10.7 %) and 21 (7.4 %) were incompletely resected, respectively, with an adjusted risk difference of 3.2 % (95 %CI -1.4 % to 7.8 %). There was no difference between the groups in terms of post-polypectomy bleeding, perforation, or abdominal pain. Independent risk factors for incomplete removal were serrated histology (odds ratio [OR] 3.96; 95 %CI 1.63 to 9.66) and hyperplastic histology (OR 2.52; 95 %CI 1.30 to 4.86) in adjusted analyses. In this randomized trial, non-inferiority for CSP could not be demonstrated. Polyps with serrated histology are more prone to incomplete resection compared with adenomas. CSP can be used safely for small polyps in routine colonoscopy practice.

Sections du résumé

BACKGROUND
Endoscopic screening with polypectomy reduces the incidence of colorectal cancer (CRC). Incomplete polyp removal may attenuate the effect of screening. This randomized trial compared cold snare polypectomy (CSP) with hot snare polypectomy (HSP) in terms of complete polyp resection.
METHODS
We included patients ≥ 40 years of age at eight hospitals in four countries who had at least one non-pedunculated polyp of 4-9 mm detected at colonoscopy. Patients were randomized 1:1 to CSP or HSP. Biopsies from the resection margins were obtained systematically after polypectomy in both groups. We hypothesized that CSP would be non-inferior to HSP, with a non-inferiority margin of 5 %. Logistic regression models were fitted to identify the factors explaining incomplete resection.
RESULTS
425 patients, with 601 polyps, randomized to either CSP or HSP were included in the analysis. Of 318 polyps removed by CSP and 283 polyps removed by HSP, 34 (10.7 %) and 21 (7.4 %) were incompletely resected, respectively, with an adjusted risk difference of 3.2 % (95 %CI -1.4 % to 7.8 %). There was no difference between the groups in terms of post-polypectomy bleeding, perforation, or abdominal pain. Independent risk factors for incomplete removal were serrated histology (odds ratio [OR] 3.96; 95 %CI 1.63 to 9.66) and hyperplastic histology (OR 2.52; 95 %CI 1.30 to 4.86) in adjusted analyses.
CONCLUSION
In this randomized trial, non-inferiority for CSP could not be demonstrated. Polyps with serrated histology are more prone to incomplete resection compared with adenomas. CSP can be used safely for small polyps in routine colonoscopy practice.

Identifiants

pubmed: 35008112
doi: 10.1055/a-1734-7952
doi:

Banques de données

ClinicalTrials.gov
['NCT02484079']

Types de publication

Clinical Trial Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

961-969

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Ina B Pedersen (IB)

Department of Medicine, Sørlandet Hospital, Kristiansand, Norway.
Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.

Anna Rawa-Golebiewska (A)

Department of Cancer Prevention and Department of Oncological Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Audrey H Calderwood (AH)

Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Lone D Brix (LD)

Department of Anesthesiology, Surgery and Intensive Care, Horsens Regional Hospital, Horsens, Denmark.

Louise B Grode (LB)

Department of Medicine, Horsens Regional Hospital, Horsens, Denmark.

Edoardo Botteri (E)

Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Department of Research, Cancer Registry of Norway, Oslo, Norway.

Marek Bugajski (M)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Department of Cancer Prevention and Department of Oncological Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.

Michal F Kaminski (MF)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Department of Cancer Prevention and Department of Oncological Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.

Wladyslaw Januszewicz (W)

Department of Cancer Prevention and Department of Oncological Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.

Hjalmar Ødegaard (H)

Department of Medicine, Sørlandet Hospital, Flekkefjord, Norway.

Britta Kleist (B)

Department of Pathology, Sørlandet hospital, Kristiansand, Norway.

Mette Kalager (M)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.

Magnus Løberg (M)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.

Michael Bretthauer (M)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.

Geir Hoff (G)

Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Department of Medicine, Telemark Hospital Skien, Skien, Norway.

Asle Medhus (A)

Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.

Øyvind Holme (Ø)

Department of Medicine, Sørlandet Hospital, Kristiansand, Norway.
Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH